NHS Blood and Transplant appoints new Chief Executive

NHS Blood and Transplant has appointed Betsy Bassis as its new Chief Executive.

Betsy has been working as the Chief Operating Officer at Defra for the past four years and has managed wide-ranging and complex transformation programmes, including large scale IT programmes. Prior to joining Defra, Betsy spent twelve years at Centrica/British Gas.

Announcing the appointment, NHS Blood and Transplant chair, Millie Banerjee, said:

“Betsy is highly motivated and enthusiastic about joining NHS Blood and Transplant with a clear focus on delivering a high-quality experience for our donors, patients and their families, whilst also creating an engaging and motivating environment for all of us who work here.”

Betsy will take up the role on 4th March 2019.

Betsy said:

“I am delighted to be joining NHS Blood and Transplant – an organisation helping people do something extraordinary by donating blood, organs, stem cells and tissues.

“I am excited to support the NHS in delivering these essential services and look forward to working with colleagues and stakeholders to do so for the benefit of patients, donors and their families.”

Betsy will take over from current interim chief executive, Sally Johnson OBE.

Sally has led the organisation since July 2018 when Ian Trenholm left to join the Care Quality Commission.

Millie said:

“I would like to take this opportunity to thank Sally for stepping up into this leadership role over the past several months and for everything she has done to steer and guide the organisation during this time.

“I know that Sally’s knowledge and experience will be invaluable to helping Betsy learn more about the vital life-saving work of NHS Blood and Transplant and to quickly get to grips with our most pressing priorities, opportunities and challenges.”

NHS Blood and Transplant aims to improve consent rates for organ donation to save the three people a day on average who die because a suitable organ for transplant isn’t available for them.

There is a constant need to recruit new blood donors to replace those who are no longer able to donate so there is sufficient blood to treat patients. Blood or the components of blood are used to treat patients with medical conditions such as anaemia, cancer blood disorders and those having surgery.

There is a need for more people from black and Asian communities to sign up as both blood and organ donors.

Return to previous page